enVVeno Medical Corporation
NVNO
$1.00
$0.033.09%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 34.84% | -24.76% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 23.60% | -26.05% | |||
| Operating Income | -23.60% | 26.05% | |||
| Income Before Tax | -48.66% | 27.71% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -48.66% | 27.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -48.66% | 27.71% | |||
| EBIT | -23.60% | 26.05% | |||
| EBITDA | -23.91% | 26.21% | |||
| EPS Basic | -48.62% | 27.61% | |||
| Normalized Basic EPS | -25.17% | 27.48% | |||
| EPS Diluted | -48.62% | 27.61% | |||
| Normalized Diluted EPS | -25.17% | 27.48% | |||
| Average Basic Shares Outstanding | 0.00% | -0.13% | |||
| Average Diluted Shares Outstanding | 0.00% | -0.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||